Rare diseases
Investigational molecules
Locations
1050 Waltham Street Suite 302, 02421-8024, United States
Keros Therapeutics Inc. focuses on clinical research in pulmonary arterial hypertension, with interest in treatments for adult participants receiving background PAH therapy. The research activity centers on cardiovascular and pulmonary vascular disease, particularly the management of elevated pulmonary pressures and related hemodynamic impairment.
The sponsor's active trial network spans multiple collaborating research sites across several countries, reflecting a therapeutic emphasis on advanced care for patients with chronic pulmonary vascular disorders.
Keros Therapeutics Inc. runs clinical trials in conditions such as Pulmonary arterial hypertension, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
